Device Vascular

Zoom 88-T Large Distal Platform

Payments companies reported to CMS as associated with Zoom 88-T Large Distal Platform. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3.0Massociated payments (2023-2025)
1,334clinicians with associated payments
1company reporting

By year

2023 $1.1M
2024 $1.1M
2025 $738K

Payments reported as associated with Zoom 88-T Large Distal Platform, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $1.1M
Neurological Surgery $1.0M
Vascular Neurology $217K
Cardiovascular Disease $212K
Neuroradiology $93K
Vascular Surgery $83K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Zoom 88-T Large Distal Platform

These are the largest totals companies reported as associated with Zoom 88-T Large Distal Platform. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
J Mocco New York, NY Neurological Surgery $560,431.01
Britton Woodward Knoxville, TN Vascular & Interventional Radiology $393,456.23
Jonathan Steinberger Portland, OR Vascular & Interventional Radiology $257,331.25
Lee Birnbaum San Antonio, TX Vascular Neurology $124,179.07
David Kim Huntsville, AL Vascular & Interventional Radiology $97,816.28
Terry Bowers Troy, MI Cardiovascular Disease $91,498.40
Robert Lookstein New York, NY Vascular & Interventional Radiology $85,200.00
Jason Carroll Englewood, CO Vascular & Interventional Radiology $84,850.43
James Milburn Covington, LA Vascular & Interventional Radiology $74,302.57
Imran Chaudry Monroe, LA Cardiovascular Disease $70,478.99

Prescribed Zoom 88-T Large Distal Platform?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.